Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.02. | City View Green Holdings Inc. Considering Spin Out as Part of Strategic Review | 196 | Newsfile | Toronto, Ontario--(Newsfile Corp. - February 12, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
CITY VIEW GREEN Aktie jetzt für 0€ handeln | |||||
23.12.24 | City View Green Holdings Inc: City View closes $234,750 first tranche of financing | 2 | Stockwatch | ||
23.12.24 | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of Its Non-Brokered Private Placement | 300 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
27.11.24 | City View Green Holdings Inc: City View Green issues 78.08 million shares for debt | 1 | Stockwatch | ||
27.11.24 | City View Green Holdings Inc. Completes Issuance of Shares in Settlement of Debt | 233 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 27, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.11.24 | City View Green Holdings Inc. Announces Completion of Strategic Review and Debt Settlements | 303 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
18.10.24 | Canadian Cannabis Edibles Producer City View Green To Raise $730K Via Private Placement | 2 | Benzinga.com | ||
17.10.24 | City View Green Holdings Inc: City View Green arranges $1-million private placement | 1 | Stockwatch | ||
17.10.24 | City View Green Holdings Inc.: City View Announces Private Placement of up to $1,000,000 and Enters into IR Agreement | 225 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles manufacturing... ► Artikel lesen | |
21.06.24 | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of its Non-Brokered Private Placement | 597 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 20, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.05.24 | City View Green Holdings Inc.: City View Extends Private Placement of up to $1,000,000 | 551 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
17.04.24 | City View Green Holdings Inc. Exits Retail Cannabis Through Ownership in Budd Hutt & Announces Director Resignation | 514 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
04.03.24 | City View Green Holdings Inc.: City View Announces Private Placement of Up To $1,000,000 | 617 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 4, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 22,050 | +1,73 % | Bayer verkauft Kunst: Millionen-Erlös gegen Schuldenberg | Bayer verkauft rund 800 Kunstwerke, darunter Werke von Warhol und Beckmann, um dringend benötigte Einnahmen zu generieren - doch angesichts von 35 Milliarden Euro Schulden ist der Effekt eher symbolisch.... ► Artikel lesen | |
PFIZER | 25,150 | +0,02 % | Bayer, Vidac Pharma, Pfizer - Demenz, Krebs, Fettleibigkeit: Die Jagd nach den Milliardenmärkten | Die Pharmabranche steckt mitten in einem Umbruch - hier geht es längst nicht mehr nur um Forschung, sondern um das große Geld. Wer jetzt die Nase vorn hat, sichert sich nicht nur Ruhm, sondern vor allem... ► Artikel lesen | |
SANOFI | 103,78 | -0,40 % | Sanofi Aktie: Ein Plus an Gelegenheiten | Der französische Pharmakonzern Sanofi zeigt eine beständige Marktentwicklung mit einer Notierung von 104,21 EUR (Stand: 15. Februar). Die Aktie weist eine robuste Performance auf, was sich in der beachtlichen... ► Artikel lesen | |
INNOCAN PHARMA | 0,151 | +0,67 % | Breaking News: InnoCan Pharma meldet erste LPT-Patentierung! | ||
DERMAPHARM | 39,350 | +1,42 % | Dermapharm: Aktie wird abgestuft | 2024 ist für Dermapharm gut verlaufen. Die Analysten von mwb research gehen davon aus, dass die Gesellschaft ihre Jahresprognose schaffen wird. Dermapharm rechnet mit einem Umsatz von 1,17 Milliarden... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
BAUSCH HEALTH | 6,982 | -0,03 % | Bausch Health Companies Inc.: Bausch Health Announces Fourth Quarter and Full-Year 2024 Results | Seventh consecutive quarter of year-over-year growth in both Revenue and Adjusted EBITDA (non-GAAP)1, delivering results at the high-end and/or exceeding 2024 guidanceFourth Quarter Consolidated Revenues... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,113 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
SINOPHARM | 2,440 | -0,20 % | Leichte Zugewinne bei der Sinopharm Group-Aktie (2,569 €) | An der Börse notiert das Wertpapier der Sinopharm Group aktuell fester. Die Aktie kostete zuletzt 2,57 Euro. Jahreschart der Sinopharm Group Ltd.-Aktie, Stand 06.01.2025 Freuen können sich gegenwärtig... ► Artikel lesen | |
INDIVA | 0,016 | 0,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
CSPC PHARMA | 0,622 | +2,78 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT FOR SYS6005 WITH RADIANCE BIOPHARMA | ||
ORAMED PHARMACEUTICALS | 2,060 | 0,00 % | Oramed Aktie: Besorgniserregende Signale? | Die Oramed Pharmaceuticals Aktie verzeichnete am 22. Februar 2025 einen signifikanten Rückgang. Der Aktienkurs fiel um 3,15 Prozent auf 2,15 USD, was einem Minus von 0,07 USD gegenüber dem vorherigen... ► Artikel lesen | |
ADASTRA | 0,212 | -3,64 % | Adastra Holdings Ltd.: Adastra Holdings Announces Resignation of Director | Langley, British Columbia--(Newsfile Corp. - February 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
CATALYST PHARMACEUTICALS | 20,550 | -0,53 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE in Japan | CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule amends, settles, converts debentures |